CH620196A5 - - Google Patents

Download PDF

Info

Publication number
CH620196A5
CH620196A5 CH207779A CH207779A CH620196A5 CH 620196 A5 CH620196 A5 CH 620196A5 CH 207779 A CH207779 A CH 207779A CH 207779 A CH207779 A CH 207779A CH 620196 A5 CH620196 A5 CH 620196A5
Authority
CH
Switzerland
Prior art keywords
group
amino acid
pca
tripeptide
pip
Prior art date
Application number
CH207779A
Other languages
German (de)
English (en)
Inventor
Daniel Frank Veber
Frederick William Holly
Ruth Foelsche-Nutt
Sandor Lajos Varga
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH620196A5 publication Critical patent/CH620196A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
CH207779A 1974-04-03 1979-03-02 CH620196A5 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45768974A 1974-04-03 1974-04-03
US05/543,734 US3959248A (en) 1974-04-03 1975-01-27 Analogs of thyrotropin-releasing hormone

Publications (1)

Publication Number Publication Date
CH620196A5 true CH620196A5 (fr) 1980-11-14

Family

ID=27038702

Family Applications (2)

Application Number Title Priority Date Filing Date
CH418375A CH617667A5 (fr) 1974-04-03 1975-04-02
CH207779A CH620196A5 (fr) 1974-04-03 1979-03-02

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH418375A CH617667A5 (fr) 1974-04-03 1975-04-02

Country Status (12)

Country Link
US (1) US3959248A (fr)
JP (2) JPS547793B2 (fr)
CH (2) CH617667A5 (fr)
CY (1) CY1071A (fr)
DE (1) DE2514381C3 (fr)
ES (1) ES436027A1 (fr)
FR (1) FR2266515B1 (fr)
GB (1) GB1473480A (fr)
HK (1) HK43480A (fr)
KE (1) KE3067A (fr)
NL (1) NL171700C (fr)
SE (1) SE425659B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449167C2 (de) * 1974-10-16 1984-05-24 Grünenthal GmbH, 5190 Stolberg N-Acyl-L-histidyl-L-prolinamide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
GB1523598A (en) * 1975-03-08 1978-09-06 Reckitt & Colmann Prod Ltd Tripeptides
JPS5944308B2 (ja) * 1976-03-23 1984-10-29 武田薬品工業株式会社 ペプタイド
JPS5920647B2 (ja) * 1976-10-01 1984-05-15 武田薬品工業株式会社 注射剤
US4161600A (en) * 1976-12-22 1979-07-17 Merck & Co., Inc. Dextro and levo-6-oxo-2-piperidinecarboxylic acid quinine salts
US4066749A (en) * 1977-01-24 1978-01-03 Merck & Co., Inc. Tetrapeptide analog of TRH
AU4125578A (en) * 1977-11-09 1979-05-17 Merck & Co Inc Tripeptides
US4215110A (en) * 1978-09-22 1980-07-29 Merck & Co., Inc. Method of treating hypertension
DE2905502C2 (de) * 1979-02-14 1982-07-15 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von LH-RH bzw. LH-RH-Analoga und Pyroglutamyl-N↑i↑m↑-dinitrophenyl-histidin
HU180926B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem
HU180925B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for producing tripeptide-amides trh-analogues,effectives on the central nerve systhem
US4254261A (en) * 1979-10-15 1981-03-03 Merck & Co., Inc. Dehydroabietylammonium salts of 6-oxo-2-piperidinecarboxylic acid
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
US4426378A (en) 1981-04-09 1984-01-17 The United States Of America As Represented By The Secretary Of The Army Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant
HU184481B (en) * 1981-10-02 1984-08-28 Richter Gedeon Vegyeszet Process for producing tripeptides for diminishing appetite
JPS59155346A (ja) * 1983-02-24 1984-09-04 Itsuro Sofue ペプタイド
CA1256650A (fr) * 1983-03-25 1989-06-27 Toshinari Tamura Procede de production de composes de 2-azetidinone-4- substitue et medicaments les contenant
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions
IT1202426B (it) * 1987-01-26 1989-02-09 Poli Ind Chimica Spa Derivato di acido tiazolidin-4-carbossilico,sua preparazione e composizioni farmaceutiche che lo contengono
US5686420A (en) * 1987-06-05 1997-11-11 Georgetown University Thyrotropin-releasing hormone analogs and method of use
US5151497A (en) * 1989-02-21 1992-09-29 Japan Tobacco Inc. Histidyl peptide derivatives
AT392949B (de) * 1989-03-17 1991-07-10 Gfm Holding Ag Vorrichtung zum abnehmen eines flaechigen werkstueckes von einer anklebenden unterfolie
DK437289D0 (da) * 1989-09-04 1989-09-04 Hans Bundgaard Prodrug derivatives of thyrotropin-releasing hormone (trh)
HU206374B (en) * 1990-09-03 1992-10-28 Richter Gedeon Vegyeszet Process for producing pentapeptide and its salts specifically inhibiting proliferation of epidermic cells, as well as pharmaceutical compositions comprising same as active ingredient
GB0125446D0 (en) * 2001-10-23 2001-12-12 Ferring Bv Novel anti-diabetic agents
AU2003228610A1 (en) * 2002-04-19 2003-11-03 University Of Florida Thyrotropin-releasing hormone analogues and their therapeutic applications
US7462595B2 (en) * 2004-09-17 2008-12-09 Prange Jr Arthur Jergen Methods for treating cancer-related fatigue

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5714337B2 (fr) * 1973-02-23 1982-03-24

Also Published As

Publication number Publication date
DE2514381A1 (de) 1975-10-09
FR2266515B1 (fr) 1978-07-28
ES436027A1 (es) 1977-05-01
SE7503366L (sv) 1975-10-04
FR2266515A1 (fr) 1975-10-31
JPS5492957A (en) 1979-07-23
CY1071A (en) 1980-10-24
DE2514381C3 (de) 1980-12-11
NL171700B (nl) 1982-12-01
JPS547793B2 (fr) 1979-04-10
NL7503023A (nl) 1975-10-07
SE425659B (sv) 1982-10-25
JPS50154247A (fr) 1975-12-12
CH617667A5 (fr) 1980-06-13
NL171700C (nl) 1983-05-02
GB1473480A (en) 1977-05-11
DE2514381B2 (de) 1980-04-17
US3959248A (en) 1976-05-25
KE3067A (en) 1980-08-08
HK43480A (en) 1980-08-22
AU7921575A (en) 1976-09-23

Similar Documents

Publication Publication Date Title
CH620196A5 (fr)
EP0034259B1 (fr) Peptides, procédé pour leur préparation et médicaments ou agents de diagnostic les contenant
EP0871653A1 (fr) Nouveaux derives d'acide amine, procede de production correspondant et compositions pharmaceutiques contenant ces composes
EP0142739B1 (fr) Dérivés d'acides aminés et leur préparation
DD217807A5 (de) Verfahren zur herstellung neuer substituierter tetrapeptide
EP0025897A2 (fr) Peptides et procédé pour leur préparation
EP0164654A2 (fr) Procédé de préparation des pentapeptides agissant sur le système immunisant et leurs produits intermédiaires
EP0523449B1 (fr) Amination réductive d'un acide aminé ou d'un dérivé d'acide aminé par un alpha-cétoacide ou un dérivé d'un alpha-cétoacide
CH616913A5 (fr)
DE2730549A1 (de) Peptidderivate und deren herstellung
CH626328A5 (en) Process for the preparation of somatostatin analogues
DE2633976A1 (de) Tripeptidderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
DE1248059B (de) Verfahren zur Herstellung bradykininwirksamer Undeca- und Dodecapeptide
CH639941A5 (en) Polypeptides, process for their preparation and their use
DE2601820A1 (de) Kathepsin d-inhibitoren
CH637915A5 (de) Angiotensin-2-antagonistisch wirkende peptide und verfahren zur herstellung dieser verbindungen.
DE3333752A1 (de) Pharmakologisch aktive peptide
EP0271443A1 (fr) Urées N,N'-disubstituées et procédé pour leur préparation
DE2515495A1 (de) Neue dekapeptide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2754770C2 (de) N-Acyltetrapeptidamide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2534086A1 (de) Polypeptide mit acth-aehnlicher wirkung, ihre salze und komplexe, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE1954794A1 (de) Peptide mit adrenocorticotroper Wirkung und Verfahren zu ihrer Herstellung
DE1518349C3 (de) Verfahren zur Herstellung eledoisinwirksamer Verbindungen
CH499497A (de) Verfahren zur Herstellung neuer Polypeptide
DE2305727A1 (de) Pentapeptide und ihre verwendung als psychopharmaka

Legal Events

Date Code Title Description
PL Patent ceased